Diabetes has become a major public health issue worldwide. It affects 285 million people, ie, 6.6 percent of the world population in the age grpup of 20 to 79 years. In India, nearly 40.9 million people suffer from diabetes, and it is anticipated that by 2025, India will have over 70 million people with diabetes. Though till recently, diabetes was considered the disease of affluent and the rich, yet with the spread of fast food chains and transformation in people's lifestyles, the disease has started affecting the poor and rural population of India. In order to contain the emerging challenge of the disease, the Ministry of Health and Family Welfare, Government of India, has launched a National Programme on Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS) initially in 10 states that comparatively have greater population of such patients. ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration.
The Special Feature in the current issue of the WISTA: Diabetes covers the NPDCS and its salient features, such as prevelance of the disease, prevention and control, awareness generation, early detection and capacity building, as also the progress achieved and status of R&D.
The feature on “Centres of Excellence” profiles Diabetes Research Institute (DRI) Miami, and Sansum Diabetes Research Institute (SDRI), Califormia While DRI leads the world in cure-focused research and transmits its findings from lab to patients in an efficient way, SDRI is engaged in developing insulin pumping device to replicate healthy pancrease.
Other features include: Watch-Out-IPR; Clinical Trials; Strategic Alliances; New Technologies/Equipments; Research & Development; Scan Around the Globe; Knowledge Spreads; and Experts Converge.
We welcome comments and suggestions.
Dr K V Swaminathan
RESEARCH & ANALYSIS TEAM
Mrs Lakshmi Swaminathan - Vice Chairman
Ms Rashmi Malhotra- Consultant
Dr Kishan Lal - Joint Director
Mr S S Kalra - Director